共 158 条
[11]
Kinoshita T(2006)Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer N Engl J Med 355 11-57
[12]
Furukawa H(2019)Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial Lancet 393 1948-21
[13]
Yamaguchi T(2012)Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial The Lancet 379 315-78
[14]
Noh SH(2013)Adjuvant chemotherapy for elderly patients with gastric cancer after D2 gastrectomy PLoS ONE 8 e53149-57
[15]
Park SR(2021)Survival analysis of elderly patients over 65 years old with stage II/III gastric cancer treated with adjuvant chemotherapy after laparoscopic D2 gastrectomy: a retrospective cohort study BMC Cancer 21 196-7
[16]
Yang HK(2013)Characteristics and prognosis of gastric cancer in patients aged >/= 70 years World J Gastroenterol 19 6568-9
[17]
Chung HC(2012)Adjuvant therapy for elderly patients with resected gastric adenocarcinoma: population-based practices and treatment effectiveness Cancer 118 248-95
[18]
Chung IJ(2015)Adjuvant chemotherapy for elderly patients (aged 70 or older) with gastric cancer after a gastrectomy with D2 dissection: a single center experience in Korea Asia Pac J Clin Oncol 11 282-49
[19]
Kim SW(2017)Management of stage III colon cancer in the elderly: practice patterns and outcomes in the general population Cancer 123 2840-9
[20]
Chang JS(2022)Patterns of Adjuvant Chemotherapy Use and Association with survival in adults 80 years and older with pancreatic adenocarcinoma JAMA Oncol 8 88-23